Streetbeat News

Products Services

ICU

SeaStar Medical Holding Corporation (Nasdaq: ICU) will present at Noble Capital Markets' NobleCon20 on December 4, 2024. The company, which develops medical devices to address hyperinflammation, will provide a company overview at the conference.

Portfolio Pulse from

November 26, 2024 | 1:15 pm

REVVF

Revolve Renewable Power Corp. has completed the acquisition of a 30 MW solar development project in Alberta, Canada, and is advancing the permitting process. This acquisition adds to their growing project pipeline in Canada.

Portfolio Pulse from

November 26, 2024 | 1:15 pm

TDY

Teledyne DALSA has launched the Z-Trak 3D Apps Studio, a software suite for in-line 3D measurement and inspection, enhancing factory automation across various industries.

Portfolio Pulse from

November 26, 2024 | 1:15 pm

PROF

Profound Medical is set to unveil its next TULSA-AI® module, the 'UA Alignment Assistant', at the upcoming RSNA and SUO meetings. The TULSA procedure's flexibility, efficacy, and ongoing CAPTAIN post-market study will be highlighted.

Portfolio Pulse from

November 26, 2024 | 1:00 pm

LH

Outcomes4Me and Labcorp have conducted a study on digital education's impact on HER2-low awareness for metastatic breast cancer patients. The results will be presented at the 2024 San Antonio Breast Cancer Symposium.

Portfolio Pulse from

November 26, 2024 | 1:00 pm

PBR

Petrobras (PBR) and Yara International have partnered to restart domestic production of the fertilizer ARLA 32 in Brazil, aiming to reduce dependency on imports.

Portfolio Pulse from

November 26, 2024 | 1:00 pm

WAVE

Eco Wave Power Global AB (NASDAQ: WAVE) is set to launch Israel's first wave energy project in collaboration with EDF Renewables IL and local authorities. The pilot station will be inaugurated on December 5, 2024, at Jaffa Port, marking a significant step in sustainable energy innovation.

Portfolio Pulse from

November 26, 2024 | 1:00 pm

BCTX

BriaCell Therapeutics Corp. will present positive overall survival data for its Bria-IMT™ plus immune checkpoint inhibitor combination in metastatic breast cancer patients at the 2024 San Antonio Breast Cancer Symposium.

Portfolio Pulse from

November 26, 2024 | 1:00 pm

INCY

Levi & Korsinsky has initiated an investigation into Incyte Corporation for potential violations of federal securities laws. This follows Incyte's announcement to pause enrollment in a Phase 2 study due to preclinical toxicology findings.

Portfolio Pulse from

November 26, 2024 | 12:45 pm

ARVN

PFE

Levi & Korsinsky has initiated an investigation into Arvinas, Inc. for potential federal securities law violations. Arvinas and Pfizer have delayed the completion of their Phase 3 trial for the breast cancer therapy vepdegestrant, moving the date from November 2024 to January 2025.

Portfolio Pulse from

November 26, 2024 | 12:45 pm